West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:00:41 2026-10-23 pm EDT
|
5-day change | 1st Jan Change | ||
| 392.15 USD | -0.48% |
|
+2.12% | +42.53% |
| Market Cap | 27.6B 24.64B 22.77B 20.63B 38.6B 2,620B 39.24B 274B 108B 1,373B 104B 101B 4,328B | P/E 2026 * |
45.7x | P/E 2027 * | 39.8x |
|---|---|---|---|---|---|
| Enterprise Value | 27.09B 24.2B 22.35B 20.26B 37.9B 2,572B 38.52B 269B 106B 1,348B 102B 99.52B 4,249B | EV / Sales 2026 * |
8.03x | EV / Sales 2027 * | 7.44x |
| Free-Float |
92.88% | Yield 2026 * |
0.23% | Yield 2027 * | 0.23% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
CBOE
| WST | Real-time | |
|
London S.E.
| 0ADY | Delayed | |
|
Tradegate
| WPS | Real-time | |
|
Deutsche Boerse AG
| WPS | Delayed | |
|
Börse Stuttgart
| WPS | Delayed | |
|
Boerse Muenchen
| WPS | Real-time | |
|
Berne S.E.
| WPS | End-of-day quote | |
|
Borsa Italiana
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -0.48% | ||
| 1 week | +2.12% | ||
| Current month | +5.77% | ||
| 1 month | +4.33% | ||
| 3 months | +10.32% | ||
| 6 months | +26.62% | ||
| Current year | +42.53% |
| 1 week | 381.98 |  | 397.16 |
| 1 month | 359.49 | | 397.16 |
| Current year | 223.83 | | 397.16 |
| 1 year | 223.83 | | 397.16 |
| 3 years | 187.43 | | 413.7 |
| 5 years | 187.43 | | 475 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Other | Director | 44 | 0.0001% | ||
| 9/15/26 | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 9/8/26 | Free | Chief Executive Officer | 51,798 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +2.12% | +27.63% | +5.83% | 27.6B | |
| +1.16% | -1.13% | -17.92% | +8.27% | 179B | |
| +0.02% | +4.24% | -19.82% | +16.53% | 118B | |
| -1.22% | +0.70% | +1.27% | +31.80% | 117B | |
| +2.29% | +17.36% | -41.94% | +9.49% | 93.26B | |
| -2.21% | -2.91% | +0.74% | +75.30% | 63.16B | |
| -1.06% | +1.75% | +13.50% | +80.00% | 55.68B | |
| -0.75% | +3.73% | +6.64% | -22.28% | 54.18B | |
| -1.13% | +0.00% | -12.25% | +31.02% | 44.15B | |
| +0.17% | +5.85% | -4.92% | -10.64% | 33.95B | |
| Average | -0.32% | +3.53% | -4.71% | +22.53% | 78.6B | |
| Weighted average by Cap. | -0.02% | +3.08% | -10.30% | +21.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 3.01B 2.78B 2.52B 4.72B 320B 4.8B 33.5B 13.26B 168B 12.67B 12.4B 529B | 3.59B 3.2B 2.96B 2.68B 5.02B 341B 5.1B 35.61B 14.1B 178B 13.46B 13.18B 563B |
| Net income | 619M 553M 510M 463M 865M 58.74B 880M 6.14B 2.43B 30.77B 2.32B 2.27B 97.02B | 710M 634M 585M 531M 993M 67.36B 1.01B 7.04B 2.79B 35.29B 2.66B 2.61B 111B |
| Net Debt | -503M -449M -415M -376M -704M -47.78B -716M -5B -1.98B -25.03B -1.89B -1.85B -78.92B | -923M -825M -762M -690M -1.29B -87.66B -1.31B -9.17B -3.63B -45.93B -3.47B -3.39B -145B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | $392.15 | -0.48% | 718,053 |
| 26-10-22 | $394.03 | +0.14% | 679,940 |
| 26-10-21 | $393.48 | +1.21% | 573,849 |
| 26-10-20 | $388.78 | +1.27% | 569,977 |
| 26-10-19 | $383.91 | -0.03% | 312,776 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
